References
- Brent GA. Mechanisms of thyroid hormone action. J Clin Invest 2012;122:3035–3043.
- Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 2006;116:2571–2579.
- Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 2007;21:193–208.
- Bergh JJ, Lin HY, Lansing L, et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005;146:2864–2871.
- Davis FB, Tang HY, Shih A, et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 2006;66:7270–7275.
- Cody V, Davis PJ, Davis FB. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids 2007;72: 165–170.
- Lin HY, Cody V, Davis FB, et al. Identification and functions of the plasma membrane receptor for thyroid hormone analogues. Discov Med 2011;11:337–347.
- Meng R, Tang HY, Westfall J, et al. Crosstalk between integrin alphavbeta3 and estrogen receptor-alpha is involved in thyroid hormone-induced proliferation in human lung carcinoma cells. PloS One 2011;6:e27547.
- Ria R, Vacca A, Ribatti D, et al. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica 2002;87:836–845.
- Usmani SZ, Heuck C, Mitchell A, et al. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica 2012;97:1761–1767.
- Cohen K, Ellis M, Khoury S, et al. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via alphavbeta3 integrin. Mol Cancer Res 2011;9:1385–1394.
- Cohen K, Ellis M, Shinderman E, et al. Relevance of the thyroid hormones-alphavbeta3 pathway in primary myeloma bone marrow cells and to bortezomib action. Leuk Lymphoma 2015;56: 1107–1114.